Hemodynamic improvement in pulmonary embolism after catheter-directed thrombectomy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Abstract Introduction / Purpose Pulmonary embolism (PE) remains a major cause of cardiovascular mortality. In intermediate–high-risk PE, interventional management with catheter-directed mechanical thrombectomy is gaining ground due to increasing evidence of its efficacy and safety. Material and Methods We present our center’s experience with a catheter-directed thrombectomy program for patients with acute intermediate/high-risk PE between April 2023 and April 2025, focusing on the improvement of invasive and non-invasive hemodynamic parameters. A total of 28 patients underwent the procedure (60% female, 36% referred from another hospital, mean age 62 years). Results The most common symptom was dyspnea (70%), with a median time to seeking care of 12 hours (IQR 1 hour – 10 days). Risk stratification scores were: PESI 108 (IQR 73–227), Bova 5±1, and Shock Index 0.98±0.3. A precipitating factor was identified in 40%, most commonly limb trauma with or without surgery, and deep vein thrombosis was present in 36%. Four patients reported COVID-19 infection within the previous 6 months, and one had an active infection. Typical echocardiographic findings were present in most cases: D-shape in 100%, McConnell sign and early systolic notch in 92%, while 60/60 sign was observed in 56%. The echocardiographic RV/LV ratio was 1.2 ± 0.1. CTPA revealed filling defects in both main pulmonary artery branches in 24/25 patients, and saddle embolism in 24%. Pre-procedural hemodynamic and respiratory parameters were: · Systolic BP: 116 ± 13 mmHg · HR: 111 ± 5 bpm · PO2:FiO2: 268 ± 64 · sPAP: 64 ± 10 mmHg · Lactate: 1.5 ± 0.5 mmol/L Immediately post-procedure, significant improvements were observed: · Systolic BP: 133 ± 9 mmHg (t=3.022 [24], p=0.013) · HR: 89 ± 8 bpm (t=5.505 [24], p
Fields of Study & Subjects
Venous Thromboembolism Diagnosis and Management
Cardiovascular and Diving-Related Complications
Pulmonary Hypertension Research and Treatments
Publication details
- Journal / source
- European Heart Journal Supplements
- Volume
- 28
- Issue
- Supplement_3
- Publication date
- 1 March 2026
- Language
- EN